Psychedelics, psychiatry and pharmacokinetics - where are we now?
Expert Opin Drug Metab Toxicol August 19, 2025 DOI: 10.1080/17425255.2025.2549987 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Key points | The abstract introduces classical psychedelics as potential treatments for depression, anxiety, and addictions, noting they differ from traditional approaches, but it does not provide a complete finding or argument due to truncation. |
Abstract
1. Classical psychedelics are gaining attention as potential treatments for a range of neuropsychiatric conditions, including depression, anxiety, and addictions [1]. Psychedelics differ from tradi...